Почетна › Рак на бели дробови со не-мали клетки › Илиноис › Evanston
Клинички испитувања за Рак на бели дробови со не-мали клетки во Evanston, IL
22 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Evanston (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Illinois Cancer Specialists /ID# 274678, Niles · на 6 милји
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Се регрутираФаза 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · на 2 милји
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Се регрутираФаза 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · на 5 милји
- Advocate Lutheran General Hospital, Park Ridge · на 8 милји
- и уште 1
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Се регрутираФаза 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 милји
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Се регрутираФаза 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Се регрутираФаза 3
- North Shore University Health System ( Site 4014), Evanston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Се регрутираФаза 3
- Illinois Cancer Specialists, Niles · на 6 милји
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Illinois Cancer Specialists, Niles · на 6 милји
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Се регрутираФаза 3
- Advocate Lutheran General Hospital, Park Ridge · на 8 милји
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Се регрутираФаза 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Се регрутираФаза 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · на 6 милји
- Advocate Medical Group Oncology, Park Ridge · на 8 милји
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Се регрутираНабљудувачка студија
- Orchard Healthcare Research Inc., Skokie · на 2 милји
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Се регрутираФаза 3
- Research Site, Niles · на 6 милји
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Се регрутираФаза 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 милји
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Се регрутираФаза 2
- Advocate Aurora Health, Park Ridge · на 8 милји
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 милји
- Advocate Lutheran General Hospital, Park Ridge · на 8 милји
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Се регрутираФаза 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 милји
- Advocate Lutheran General Hospital, Park Ridge · на 8 милји
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 милји
- Advocate Lutheran General Hospital, Park Ridge · на 8 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 милји
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Се регрутираНабљудувачка студија
- Advocate Lutheran General Hospital, Park Ridge · на 8 милји
GEMINI-NSCLC: NSCLC Biomarker Study
Се регрутираНабљудувачка студија
- Northwestern University, Evanston
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY121 студија
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH57 студии
- Washington, DC55 студии
Други студии во Evanston
- Рак на бели дробови19 студии
- Рак на дојка13 студии
- Дебелина12 студии
- Акутна миелоидна леукемија11 студии
- Прекумерна телесна тежина10 студии
- Колоректален карцином10 студии
- Рак (сите типови)9 студии
- Кронова болест9 студии
- Улцерозен колитис9 студии
- Рак на простата9 студии
- Меланом8 студии
- Атријална фибрилација8 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.